台灣臨床試驗主持人資料庫|TPIDB

2017-03-17 - 2023-03-17

Phase III

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Compensated Cirrhosis due to Nonalcoholic Steatohepatitis (NASH)

Condition/Disease

Nonalcoholic Steatohepatitis
Test Drug

Selonsertib

Participate Sites
5Sites

Terminated4Sites

黃志富

Kaohsiung Municipal Gangshan Hospital

未分科

沈一嫻

Linkou Chang Gung Medical Foundation

Division of General Internal Medicine

2017-03-03 - 2023-02-28

Phase III

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis

Condition/Disease

Nonalcoholic Steatohepatitis(NASH)
Test Drug

Selonsertib

Participate Sites
20Sites

Terminated18Sites

黃志富

Kaohsiung Municipal Gangshan Hospital

未分科

沈一嫻

Linkou Chang Gung Medical Foundation

Division of General Internal Medicine

2017-03-21 - 2020-07-21

Phase III

A Phase 3, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Switching from Tenofovir Disoproxil Fumarate (TDF) 300 mg QD to Tenofovir Alafenamide (TAF) 25 mg QD in Subjects with Chronic Hepatitis B who are Virologically Suppressed

Condition/Disease

Chronic Hepatitis B
Test Drug

Tenofovir Alafenamide Tablets

Participate Sites
7Sites

Terminated5Sites

莊萬龍

Kaohsiung Municipal Gangshan Hospital

未分科

2015-12-22 - 2015-12-22

Phase II

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-center Study to Evaluate the Safety and Efficacy of GS-9620 in combination with Tenofovir Disoproxil Fumarate (TDF) for the Treatment of Subjects with Chronic Hepatitis B and who are currently not on Treatment

Condition/Disease

Chronic Hepatitis B
Test Drug

GS-9620,Tenofovir Disoproxil Fumarate (TDF)

Participate Sites
3Sites

Not yet recruiting1Sites

Terminated2Sites

莊萬龍

Kaohsiung Municipal Gangshan Hospital

Digestive System Department

2018-08-28 - 2021-04-12

Phase II

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-center Study to Evaluate the Safety, Tolerability and Antiviral Activity of GS-9688 in Viremic Adult Subjects with Chronic Hepatitis B who are not currently on Treatment

Condition/Disease

Viremic Chronic Hepatitis B
Test Drug

GS-9688 Film-coated Tablets, 1.5mg

Participate Sites
5Sites

Terminated3Sites

莊萬龍

Kaohsiung Municipal Gangshan Hospital

未分科

2017-06-01 - 2019-12-31

Phase II

Placebo-controlled, Double-blind, Randomized Study of Aerucin® as Adjunct Therapy to Antibiotics in the Treatment of P. Aeruginosa Pneumonia

Condition/Disease

Pseudomonas Aeruginosa Pneumonia
Test Drug

Aerucin（aerubumab，AR-105）

Participate Sites
11Sites

Terminated10Sites

許超群

Kaohsiung Municipal Gangshan Hospital

未分科

2017-02-17 - 2020-12-17

Phase III

Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn's Disease

Condition/Disease

Active Crohn’s Disease
Test Drug

Filgotinib, 100 mg and 200 mg per tablet

Participate Sites
14Sites

Recruiting9Sites

Terminated3Sites

吳登強

Kaohsiung Municipal Gangshan Hospital

未分科

邱正堂

Linkou Chang Gung Medical Foundation

2018-01-01 - 2020-05-01

Phase III

A phase 3, randomized, double-blind, placebo-controlled, multicenter trial to evaluate the efficacy and safety of Pimodivir combined with standard care treatment in adolescents, adults, and elderly hospitalized patients with influenza A

Condition/Disease

Influenza A Infection
Test Drug

Pimodivir

Participate Sites
5Sites

Terminated4Sites

許超群

Kaohsiung Municipal Gangshan Hospital

未分科

2016-01-01 - 2017-12-08

Phase III

A Randomized, Double-Blind, Double-Dummy, Multicenter, Active-Controlled Study to Evaluate the Efficacy and Safety of Vedolizumab IV Compared to Adalimumab SC in Subjects With Ulcerative Colitis

Condition/Disease

Ulcerative Colitis
Test Drug

ENTYVIO; KYNTELES

Participate Sites
5Sites

Terminated4Sites

吳登強

Kaohsiung Municipal Gangshan Hospital

未分科

2015-11-01 - 2026-12-31

Phase III

A Phase 3, Randomized, Efficacy and Safety Study of Enzalutamide Plus Leuprolide, Enzalutamide Monotherapy, and Placebo Plus Leuprolide in Men With High-Risk Nonmetastatic Prostate Cancer Progressing After Definitive Therapy

Condition/Disease

Prostate Cancer
Test Drug

Enzalutamide (formerly MDV3100)

Participate Sites
9Sites

Terminated7Sites

黃書彬

Kaohsiung Municipal Gangshan Hospital

未分科

林永昌

Linkou Chang Gung Medical Foundation

Division of Hematology & Oncology

Search Result

List